Table 4 |
||
|
Fecal counts of total Lactobacilli from IP group at d 16 and d 30. |
||
|
Treatments |
Lactobacilli |
|
|
|
||
|
d16 |
d30 |
|
|
|
||
|
CTL- |
9.01 ± 0.08 |
8.70 ± 0.17b |
|
CTL+ |
8.83 ± 0.16 |
8.89 ± 0.18ab |
|
LGG1 |
9.04 ± 0.12 |
8.86 ± 0.10ab |
|
LGG2 |
8.80 ± 0.28 |
9.03 ± 0.13a |
|
|
||
|
CTL-: PBS; CTL+: CMP (10 mg/mouse); LGG1: CTL+ mice supplemented with LGG for 5 weeks and LGG2: CTL+ mice supplemented with LGG for 4 weeks. Data are presented as the mean log10 colony forming units/g ± standard deviation of fecal sample. For each bacterium, treatment means with different letters in the same column differ, P ≤ 0.05. |
||
|
Thang et al. Allergy, Asthma & Clinical Immunology 2011 7:20 doi:10.1186/1710-1492-7-20 |
||